Mimetogen Pharmaceuticals' Other Investors

Mimetogen Pharmaceuticals raised a round of funding on , .

Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. The company desig…

Articles about Mimetogen Pharmaceuticals' Other Investors: